Pharmacogenomic clinical decision support design and multi-site process outcomes analysis in the eMERGE Network

To better understand the real-world effects of pharmacogenomic (PGx) alerts, this study aimed to characterize alert design within the eMERGE Network, and to establish a method for sharing PGx alert response data for aggregate analysis. Seven eMERGE sites submitted design details and established an alert logging data dictionary. Six sites participated in a pilot study, sharing alert response data from their electronic health record systems. PGx alert design varied, with some consensus around the use of active, post-test alerts to convey Clinical Pharmacogenetics Implementation Consortium recommendations. Sites successfully shared response data, with wide variation in acceptance and follow rates. Results reflect the lack of standardization in PGx alert design. Standards and/or larger studies will be necessary to fully understand PGx impact. This study demonstrated a method for sharing PGx alert response data and established that variation in system design is a significant barrier for multi-site analyses.

[1]  Diane L. Seger,et al.  Overrides of medication-related clinical decision support alerts in outpatients , 2014, J. Am. Medical Informatics Assoc..

[2]  R. Altman,et al.  The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems , 2017, Clinical pharmacology and therapeutics.

[3]  Casey Lynnette Overby,et al.  Making pharmacogenomic-based prescribing alerts more effective: A scenario-based pilot study with physicians , 2015, J. Biomed. Informatics.

[4]  Suzette J. Bielinski,et al.  Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multi-Center Pilot for Pre-Emptive Pharmacogenomics in Electronic Health Record Systems , 2014, Clinical pharmacology and therapeutics.

[5]  Ching-Hon Pui,et al.  PG4KDS: A model for the clinical implementation of pre‐emptive pharmacogenetics , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

[6]  Joshua C. Denny,et al.  Attitudes of Clinicians Following Large-Scale Pharmacogenomics Implementation , 2015, The Pharmacogenomics Journal.

[7]  Nikhil Wagle,et al.  Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. , 2016, American journal of human genetics.

[8]  Casey Lynnette Overby,et al.  Implementation of pharmacogenetics: The University of Maryland personalized anti‐platelet pharmacogenetics program , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

[9]  Suzette J. Bielinski,et al.  A conceptual model for translating omic data into clinical action , 2015, Journal of pathology informatics.

[10]  Kevin B. Johnson,et al.  Electronic health record design and implementation for pharmacogenomics: a local perspective , 2013, Genetics in Medicine.

[11]  H. Willard,et al.  Genomic and personalized medicine: foundations and applications. , 2009, Translational research : the journal of laboratory and clinical medicine.

[12]  R. Altman,et al.  Pharmacogenomics‐Based Point‐of‐Care Clinical Decision Support Significantly Alters Drug Prescribing , 2017, Clinical pharmacology and therapeutics.

[13]  Justin Starren,et al.  Crossing the omic chasm: a time for omic ancillary systems. , 2013, JAMA.

[14]  Michelle Whirl-Carrillo,et al.  Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC) , 2016, Genetics in Medicine.

[15]  Gianrico Farrugia,et al.  Multidisciplinary Model to Implement Pharmacogenomics at the Point of Care , 2016, Genetics in Medicine.

[16]  Jon W. McKeeby,et al.  Integrating pharmacogenetic information and clinical decision support into the electronic health record , 2014, J. Am. Medical Informatics Assoc..

[17]  Kevin Meldrum,et al.  Department of Veterans Affairs' Computerized Patient Record System , 1999, AMIA.

[18]  Kensaku Kawamoto,et al.  Clinical decision support for genetically guided personalized medicine: a systematic review , 2013, J. Am. Medical Informatics Assoc..

[19]  Melissa A. Basford,et al.  The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future , 2013, Genetics in Medicine.

[20]  Janet E Olson,et al.  Integrating Pharmacogenomics into Clinical Practice: Promise vs Reality. , 2016, The American journal of medicine.

[21]  Kensaku Kawamoto,et al.  Standards for Scalable Clinical Decision Support: Need, Current and Emerging Standards, Gaps, and Proposal for Progress , 2010, The open medical informatics journal.

[22]  Dan M. Roden,et al.  Implementing genomic medicine in the clinic: the future is here , 2013, Genetics in Medicine.

[23]  Thomas H. Payne,et al.  Evaluating clinical decision support systems: monitoring CPOE order check override rates in the Department of Veterans Affairs' Computerized Patient Record System. , 2008, Journal of the American Medical Informatics Association : JAMIA.

[24]  Wendy A. Wolf,et al.  The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies , 2011, BMC Medical Genomics.

[25]  Marc Berg,et al.  Overriding of drug safety alerts in computerized physician order entry. , 2006, Journal of the American Medical Informatics Association : JAMIA.

[26]  J M Pulley,et al.  Physician response to implementation of genotype‐tailored antiplatelet therapy , 2016, Clinical pharmacology and therapeutics.

[27]  Jeffrey C. Hall,et al.  The CLIPMERGE PGx Program: Clinical Implementation of Personalized Medicine Through Electronic Health Records and Genomics–Pharmacogenomics , 2013, Clinical pharmacology and therapeutics.

[28]  M. Relling,et al.  Development and use of active clinical decision support for preemptive pharmacogenomics , 2013, Journal of the American Medical Informatics Association : JAMIA.

[29]  Keith Marsolo,et al.  Practical considerations in genomic decision support: The eMERGE experience , 2015, Journal of pathology informatics.

[30]  Teri E Klein,et al.  Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. , 2015, Annual review of pharmacology and toxicology.

[31]  Sara Chandros Hull,et al.  Erratum: Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine (American Journal of Human Genetics (2016) 98(6) (1067–1076) (S0002929716301069) (10.1016/j.ajhg.2016.04.011)) , 2016 .

[32]  Peter Tarczy-Hornoch,et al.  Usability evaluation of pharmacogenomics clinical decision support aids and clinical knowledge resources in a computerized provider order entry system: A mixed methods approach , 2014, Int. J. Medical Informatics.

[33]  PJ Caraballo,et al.  Electronic Medical Record‐Integrated Pharmacogenomics and Related Clinical Decision Support Concepts , 2017, Clinical pharmacology and therapeutics.